Autoimmune Disease Drugs Market Trends

Growth Drivers

• Improvement In Government Regulations Regarding Drug Approvals To Drive Autoimmune disease treatment Market
  Recently, a few autoimmune disease treatment have received approvals for sale in the market. For instance, RITUXIN is a drug manufactured by Genentech, which received FDA approval for the treatment of rheumatoid arthritis. Various other drugs are still in the clinical trials stage and observing positive results. This is anticipated to become a major factor for the growth of autoimmune disease treatment market over the forecast period. The increasing research and development in the area of autoimmune disease is predicted to lead to more drug approvals in future.
• Rising Awareness about Autoimmune Disease to Boost the Market Growth
  Growing prevalence of various autoimmune diseases poses a high risk to individuals, especially the elderly population. Rheumatoid arthritis is an autoimmune disease in which the immune system attacks the joints in the body, commonly those in hands, knees and wrists. This causes inflammation in the affected body part and inhibits normal body functioning. According to Centers for Disease Prevention and Control, around 22.7% or 54.4 million adults in America had doctor-diagnosed arthritis as per the National Health Interview Survey 2013-3015, with a higher prevalence in women (23.5%) than in men (18.1%). The growing demand for reducing the effects of this disorder is anticipated to result in growth of the market.

Challenges

• High Cost Of Treatment To Restrict The Market Growth
  The high cost of treatment for autoimmune disease coupled with availability of alternate treatment methods in the market are some major factors estimated to hinder the growth of autoimmune disease market over the forecast period.